Can Exercise Capacity Assessed by the 6 Minute Walk Test Predict the Development of Major Adverse Cardiac Events in Patients with STEMI after Fibrinolysis?: e99035

Background To assess the added value of the 6 minute walk test distance (6MWTD) in the risk-stratification methods for patients with ST -segment elevation myocardial infarction (STEMI) treated with fibrinolysis. Methodology/Principal Findings This is a prospective cohort study of one hundred consecu...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2014-06, Vol.9 (6)
Main Authors: Hassan, Ayman KM, Dimitry, Salwa R, Agban, George W
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Background To assess the added value of the 6 minute walk test distance (6MWTD) in the risk-stratification methods for patients with ST -segment elevation myocardial infarction (STEMI) treated with fibrinolysis. Methodology/Principal Findings This is a prospective cohort study of one hundred consecutive patients with STEMI, who had received fibrinolysis, at Assuit University Hospital. All patients underwent 6MWT pre- discharge and were followed up for 3 months to monitor the incidence of major adverse cardiac events (MACE). Patients were divided into 3 groups according to the level of 6MWTD (level I>450 m, level II = 300-450 m and level III450 m), patients in level III (
ISSN:1932-6203
DOI:10.1371/journal.pone.0099035